Issues
Volume 222 Issue 7
Cover image credit: New Africa/stock.adobe.com
Editor’s choice
Physicians as advocates: an enduring calling
“Medicine is a social science and politics is nothing but medicine on a grand scale”1 Many MJA readers will be familiar with this oft quoted phrase from the 19th century German physician Rudolf Virchow. In his landmark report of a typhus epidemic, Virchow pointed out the links between poverty and the spread of disease. The role of the medical profession, it follows, is not simply to treat individual patients but to also attend to the social conditions that underpin poor health outcomes. Consideration of the social determinants of health, as we now call them, is a fundamental part of contemporary public health research and practice and an area the MJA frequently publishes on. In this issue of the Journal, for instance, research by Rubenis and colleagues2 investigates place‐based disparities in care for cardiovascular diseases. They find that despite recent improvements, patients living in regional and remote areas of New South Wales admitted to hospital with heart failure experience persistently higher in‐hospital mortality compared with their metropolitan‐dwelling counterparts. Likewise, writing in a perspective article, Robertson and colleagues3 explore the many barriers that exist to research participation by people with vision impairment and describe strategies for improving participation by changing information provision and data collection methods. Although it is widely accepted that the state of our social world has an enormous influence on health, the role of health experts in moving beyond merely describing and explaining to seeking to transform social conditions to improve health remains contested. This is especially when powerful interests are at play. In such cases, it is common for physicians and researchers to be extorted to stay in their narrowly defined biomedical “lane”, or for those within the profession to worry about tainting their appearance of objective, evidence‐driven thinking by engaging in debates of a political nature. Bilgrami and colleagues4 address this tension in an article on armed conflict and the role of physician advocacy. Globally, attacks on health care — such as the killing, kidnapping and arrest of health care workers, hijacking of medical supplies, obstruction of patients from accessing care, and the bombing, looting and occupation of health facilities — are on the rise. Despite these devastating events, the authors note “most medical associations and societies have been inconsistent when it comes to advocating for the protection of health care workers in conflicts. An argument commonly put forth in recent years is that such organisations must remain apolitical”. Bilgrami and colleagues contrast this approach with notable historical and contemporary examples of successful physician advocacy efforts, as well as with their view of the norms and responsibilities at the heart of ethical medical practice. Ultimately, they conclude that “physicians have been unconscionably silent in recent years and must now integrate professional and political activities if they are to live up to the highest ideals of the profession”. There are lessons here that extend far beyond the issue of armed conflict. In the United States, for instance, the coalescence of anti‐science and anti‐human rights agendas under the Trump administration has placed academic independence and public health under attack, including with direct effects in Australia.5,6 Researchers and practitioners are facing very tangible consequences for engaging with the social determinants of health, be it around gender, sexuality, race, or health inequities more generally.7 Grants are being cancelled.8 Public health programs are being dismantled.9,10 Universities are being intimidated.11 Credible health information is being censored12,13 and purveyors of misinformation are being elevated to high places.14,15 What recent events in the US have demonstrated is that regardless of whether scientific and medical institutions seek to appear apolitical, political actors nonetheless deeply appreciate the power that health and medical experts hold in our societies and are prepared to act accordingly in pursuit of their dangerous agendas. Virchow's instruction to the medical profession is as relevant today as it was over 150 years ago.
Elizabeth Zuccala
Perspective
Dismantling barriers to research and clinical care for individuals with a vision impairment
Accessibility in research is an ongoing commitment that will continue to change based on the needs and preferences of the community. We must weigh up the impact of incorporating accessibility practices in research with the social cost of forgoing them
Eden G Robertson · Kate Hetherington · Meredith Prain · Julia Hall · Leighton Boyd AM · Rosemary Boyd OAM · Emily Shepard · Hollie Feller · Sally Karandrews · Fleur O'Hare · Kanae Yamamoto · Matthew P Simunovic · Robyn V Jamieson · Alan Ma · Lauren Ayton AM · Anai Gonzalez‐Cordero
Using patient‐reported outcome measures in clinical trials: perspectives for and against a modular approach
There is growing interest in minimising the burden for patients when completing patient-reported outcome measures (PROMs). We explore different perspectives for and against adopting a modular approach for PROM inclusion in clinical trials.
Carrie‐Anne Ng · Jessica Roydhouse · Tim Luckett · Richard De Abreu Lourenco · Brendan Mulhern
Physician advocacy, international humanitarian law, and the protection of health care workers in conflict zones
International humanitarian law in its current form cannot be relied upon as the sole mechanism of prevention and response to attacks on health care in conflict zones
Irma Bilgrami · Christopher Guy · Vanessa Carnegie · Sandra Lussier
Medical education
Updating the diagnosis and management of elevated serum ferritin levels in the era of routine ferritin testing of blood donors by Australian Red Cross Lifeblood
Guidance on how to investigate and manage elevated serum ferritin levels
Gary D Zhang · James Chen · Daniel M Johnstone · Martin B Delatycki · Katie Allen · John K Olynyk
Editorial
Strong medication overdose data, but we need to consider both toxicity and therapeutic need when prescribing
Physicians should know which medications should be prescribed in limited quantities and only after safer alternatives have been tried
Angela L Chiew · Geoffrey K Isbister
Research
The relative toxicity of medicines detected after poisoning suicide deaths in Australia, 2013–19: a data linkage case series study
More toxic medicines should be supplied in limited quantities and their dispensing to individuals monitored
Jessy Lim · Nicholas A Buckley · Kate Chitty · Andrea L Schaffer · Jennifer Schumann · Zein Ali · Rose Cairns
Geographic remoteness‐based differences in in‐hospital mortality among people admitted to NSW public hospitals with heart failure, 2002–21: a retrospective observational cohort study
Targeted programs could improve outcomes for people in regional and remote Australia with heart failure
Imants Rubenis · Gregory Harvey · Karice Hyun · Vincent Chow · Leonard Kritharides · Andrew P Sindone · David B Brieger · Austin CC Ng
Consensus statement
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1
This two-part position statement provides a practical resource for clinicians on current best-practice consensus recommendations for managing adults with MS in the Australian and New Zealand health care settings
the MS Interest Group, Australian and New Zealand Association of Neurologists
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2
A safe, effective and comprehensive approach to managing MS is crucial for improving long term outcomes and quality of life in individuals affected by MS
the MS Interest Group, Australian and New Zealand Association of Neurologists
Letter to the editor
Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS‐CoV‐2 Omicron wave
Mulu Woldegiorgis · Rosemary J Korda · Paul V Effler
What's past is prologue
Michael Skilton
The potential of maternal and child health service data in Australia: how lessons from the COVID‐19 pandemic can accelerate data‐informed decision making
Ashleigh Shipton · Meredith O'Connor · Melissa Wake · Sharon Goldfeld · Helen Lees · Catina Adams · Kristina Edvardsson · Leesa Hooker · Jatender Mohal · Rhiannon M Pilkington · Fiona K Mensah
Exploring the role of urine drug screening in opioid agonist therapy
Grace FitzGerald · Sione Crawford · Adrian J Dunlop · Jon Cook · Dean Membrey · Paul MacCartney · Thileepan Naren
Cultural safety, the LGBTQI+ community and international medical graduate training
Cindy Towns · Charlene Rapsey · Rhea Liang
The 2024 report of the MJA–Lancet Countdown on health and climate change: Australia emerging as a hotspot for litigation
Paul J Beggs · Alistair J Woodward · Stefan Trueck · Martina K Linnenluecke · Hilary Bambrick · Anthony G Capon · Zerina Lokmic‐Tomkins · Jacqueline Peel · Kathryn Bowen · Ivan C Hanigan · Nicolas Borchers Arriagada · Troy J Cross · Sharon Friel · Donna Green · Maddie Heenan · Ollie Jay · Harry Kennard · Arunima Malik · Celia McMichael · Mark Stevenson · Sotiris Vardoulakis · Aditya Vyas · Marina B Romanello · Maria Walawender · Ying Zhang
The Fossil Fuel Non‐Proliferation Treaty: what it is, its importance for health, and why Australia should endorse it
Philomena Colagiuri · Jake TW Williams · Paul J Beggs · Ying Zhang
Tick tock: the travelling time bomb
Matthew AK Martin · Maxwell E Olenski